-
Publication Venue For
-
Delivering on the Promise of Technology to Augment Behavioral Interventions in Type 2 Diabetes..
46:918-920.
2023
-
"The Times They Are A-Changin'" at Diabetes Care..
46:3-5.
2023
-
Observational Evaluations of Disease Management Programs for Diabetes: The Proof Is in the Concept..
45:2808-2810.
2022
-
Health Care Utilization Trends Across the Transition Period in a National Cohort of Adolescents and Young Adults With Type 1 Diabetes..
45:2509-2517.
2022
-
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)..
45:2753-2786.
2022
-
Neighborhood Socioeconomic Deprivation and 30-Day Mortality and Readmission for Patients Admitted for Diabetes Management..
45:e169-e170.
2022
-
Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment..
45:1754-1761.
2022
-
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association..
45:1670-1690.
2022
-
Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Patients With Painful Diabetic Neuropathy Refractory to Conventional Treatments: 12-Month Results From a Randomized Controlled Trial..
45:e3-e6.
2022
-
Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database..
44:2542-2551.
2021
-
Association of Metabolic Phenotypes With Coronary Artery Disease and Cardiovascular Events in Patients With Stable Chest Pain..
44:1038-1045.
2021
-
A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes..
44:8-10.
2021
-
Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data..
43:2485-2492.
2020
-
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial..
43:e108-e110.
2020
-
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial..
43:1803-1812.
2020
-
Erratum. 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2020;43:487-493..
43:1670.
2020
-
Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL..
43:643-652.
2020
-
Erratum. Hostility, race, and glucose metabolism in nondiabetic individuals. Diabetes Care 2002;25:835-839..
43:691.
2020
-
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)..
43:487-493.
2020
-
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial..
43:446-452.
2020
-
The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE..
43:e22-e24.
2020
-
Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)..
43:374-381.
2020
-
Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study..
43:161-168.
2020
-
Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590-1599..
42:2347.
2019
-
Response to Comment on Elliott et al. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Diabetes Care 2019;42:1290-1296..
42:e156.
2019
-
Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials..
42:e119-e121.
2019
-
Longitudinal Changes in Depression Symptoms and Glycemia in Adults With Type 1 Diabetes..
42:1194-1201.
2019
-
Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up..
42:1290-1296.
2019
-
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)..
42:1075-1080.
2019
-
Comment on Davis et al. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial. Diabetes Care 2019;42:157-163..
42:e95.
2019
-
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report..
42:731-754.
2019
-
Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study..
42:486-493.
2019
-
Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL..
42:318-326.
2019
-
An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs..
41:2509-2516.
2018
-
Fasting Glucose Variability in Young Adulthood and Cognitive Function in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study..
41:2579-2585.
2018
-
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)..
41:2669-2701.
2018
-
Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts..
41:1590-1599.
2018
-
Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?.
41:1560-1562.
2018
-
Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial..
41:1391-1399.
2018
-
John Denis McGarry, PhD: A Remembrance of a Master Metabolic Physiologist..
41:1330-1336.
2018
-
Effect of High-Deductible Insurance on High-Acuity Outcomes in Diabetes: A Natural Experiment for Translation in Diabetes (NEXT-D) Study..
41:940-948.
2018
-
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype..
41:596-603.
2018
-
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum..
41:14-31.
2018
-
The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial..
41:96-103.
2018
-
Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial..
40:1763-1770.
2017
-
Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes..
40:1787-1789.
2017
-
What End Users and Stakeholders Want From Automated Insulin Delivery Systems..
40:1453-1461.
2017
-
Maternal BMI and Glycemia Impact the Fetal Metabolome..
40:902-910.
2017
-
Targeted Metabolomics Demonstrates Distinct and Overlapping Maternal Metabolites Associated With BMI, Glucose, and Insulin Sensitivity During Pregnancy Across Four Ancestry Groups..
40:911-919.
2017
-
Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions..
40:e65-e66.
2017
-
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)..
40:494-501.
2017
-
Management of Hemoglobin Variants Detected Incidentally in HbA1c Testing: A Common Problem Currently Lacking a Standard Approach..
40:e8-e9.
2017
-
Pancreatic Safety of Sitagliptin in the TECOS Study..
40:164-170.
2017
-
Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial..
40:63-68.
2017
-
Diabetes Care: "Taking It to the Limit One More Time"..
40:3-6.
2017
-
Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS..
39:2304-2310.
2016
-
A Smartphone Application to Deliver a Treat-to-Target Insulin Titration Algorithm in Insulin-Naive Patients With Type 2 Diabetes: A Pilot Randomized Controlled Trial..
39:e174-e176.
2016
-
Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010..
39:1643-1649.
2016
-
Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia..
39:1230-1240.
2016
-
Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth..
39:934-940.
2016
-
Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift..
39:e71-e73.
2016
-
Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS)..
39:582-588.
2016
-
Diabetes and the Association of Postoperative Hyperglycemia With Clinical and Economic Outcomes in Cardiac Surgery..
39:408-417.
2016
-
Building Momentum: Taking on the Real “Issues” of Diabetes Care!.
39:10-12.
2016
-
Momentary Predictors of Insulin Restriction Among Adults With Type 1 Diabetes and Eating Disorder Symptomatology..
38:2025-2032.
2015
-
Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration..
38:1921-1929.
2015
-
Erratum. Improving diabetes management and cardiovascular risk factors through peer-led self-management support groups in western Kenya. Diabetes Care 2015;38:e110-e111..
38:1993.
2015
-
Clinical Utility of SMBG: Recommendations on the Use and Reporting of SMBG in Clinical Research..
38:1627-1633.
2015
-
Improving Diabetes Management and Cardiovascular Risk Factors Through Peer-Led Self-management Support Groups in Western Kenya..
38:e110-e111.
2015
-
Response to comment on Tay et al. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial. Diabetes Care 2014;37:2909-2918..
38:e65-e66.
2015
-
Trends in diabetes incidence: the Framingham Heart Study..
38:482-487.
2015
-
Rationale and design of the Vitamin D and Type 2 Diabetes (D2d) study: a diabetes prevention trial..
37:3227-3234.
2014
-
A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial..
37:2909-2918.
2014
-
Comment on Doyle et al. Closed-loop artificial pancreas systems: engineering the algorithms. Diabetes Care 2014;37:1191-1197..
37:e226-e227.
2014
-
Diabetic kidney disease: a report from an ADA Consensus Conference..
37:2864-2883.
2014
-
Response to comments on Evert et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care 2013;36:3821-3842..
37:e102-e103.
2014
-
Ocular anti-VEGF therapy for diabetic retinopathy: overview of clinical efficacy and evolving applications..
37:900-905.
2014
-
Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry..
37:173-179.
2014
-
Metabolomics reveals broad-scale metabolic perturbations in hyperglycemic mothers during pregnancy..
37:158-166.
2014
-
Nutrition therapy recommendations for the management of adults with diabetes..
37 Suppl 1:S120-S143.
2014
-
Nutrition therapy recommendations for the management of adults with diabetes..
36:3821-3842.
2013
-
Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial..
36:3613-3619.
2013
-
Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review..
36:3337-3345.
2013
-
Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort..
36:3208-3215.
2013
-
Impact of baseline insulin regimen on glycemic response to a group medical clinic intervention..
36:1954-1960.
2013
-
Screening for diabetes and prediabetes should be cost-saving in patients at high risk..
36:1981-1987.
2013
-
Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study..
36:1590-1596.
2013
-
Associations between diabetes, leanness, and the risk of death in the Japanese general population: the Jichi Medical School Cohort Study..
36:1186-1192.
2013
-
Retinal vascular caliber as a biomarker for diabetes microvascular complications..
36:750-759.
2013
-
Neck circumference and the development of cardiovascular disease risk factors in the Framingham Heart Study..
36:e3.
2013
-
Thalamic activation during slightly subphysiological glycemia in humans..
35:2570-2574.
2012
-
When the blood glucose and the HbA(1c) don't match: turning uncertainty into opportunity..
35:2421-2423.
2012
-
Pharmacodynamic effect of cilostazol plus standard clopidogrel versus double-dose clopidogrel in patients with type 2 diabetes undergoing percutaneous coronary intervention..
35:2194-2197.
2012
-
Improvement in outcomes of clinical islet transplantation: 1999-2010..
35:1436-1445.
2012
-
Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial..
35:1525-1531.
2012
-
Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets..
35:1446-1454.
2012
-
Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample..
35:1310-1315.
2012
-
Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease..
35:994-1001.
2012
-
Early retinal arteriolar changes and peripheral neuropathy in diabetes..
35:1098-1104.
2012
-
Effect of extended-release niacin on new-onset diabetes among hyperlipidemic patients treated with ezetimibe/simvastatin in a randomized controlled trial..
35:857-860.
2012
-
Global prevalence and major risk factors of diabetic retinopathy..
35:556-564.
2012
-
Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes..
35:599-604.
2012
-
Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010..
35:434-445.
2012
-
Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes..
35:173-174.
2012
-
Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the framingham heart study..
34:2464-2470.
2011
-
Retinal vascular geometry predicts incident retinopathy in young people with type 1 diabetes: a prospective cohort study from adolescence..
34:1622-1627.
2011
-
Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow..
34:1389-1393.
2011
-
Diabetic retinopathy in 2011: further insights from new epidemiological studies and clinical trials..
34:1066-1067.
2011
-
Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids..
34:474-479.
2011
-
Exercise-induced changes in metabolic intermediates, hormones, and inflammatory markers associated with improvements in insulin sensitivity..
34:174-176.
2011
-
Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms..
34:121-125.
2011
-
Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes..
34:145-150.
2011
-
Interactions of dietary whole-grain intake with fasting glucose- and insulin-related genetic loci in individuals of European descent: a meta-analysis of 14 cohort studies..
33:2684-2691.
2010
-
Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes..
33:2156-2163.
2010
-
Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes..
33:1503-1508.
2010
-
Screening adults for pre-diabetes and diabetes may be cost-saving..
33:1484-1490.
2010
-
Alterations in retinal microvascular geometry in young type 1 diabetes..
33:1331-1336.
2010
-
Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia..
33:1021-1024.
2010
-
History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway..
32:2193-2199.
2009
-
Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy..
32:2075-2080.
2009
-
Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes..
32:2081-2083.
2009
-
Effects of exercise training intensity on pancreatic beta-cell function..
32:1807-1811.
2009
-
Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis..
32:1704-1709.
2009
-
Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women..
32:1678-1683.
2009
-
Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome..
32:857-859.
2009
-
Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program..
32:915-920.
2009
-
One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes..
32:215-220.
2009
-
Performance of comorbidity, risk adjustment, and functional status measures in expenditure prediction for patients with diabetes..
32:75-80.
2009
-
Quantitative assessment of early diabetic retinopathy using fractal analysis..
32:106-110.
2009
-
Offspring of patients with diabetes exhibit a clustering of psychosocial distress and inflammatory and metabolic risk factors..
31:e86.
2008
-
Ocular associations of diabetes other than diabetic retinopathy..
31:1905-1912.
2008
-
Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes..
31:1842-1846.
2008
-
Health care use and costs associated with use of a health club membership benefit in older adults with diabetes..
31:1562-1567.
2008
-
Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study..
31:1582-1584.
2008
-
Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study..
31:1349-1354.
2008
-
Influence of flickering light on the retinal vessels in diabetic patients: response to Mandecka et al..
31:e51.
2008
-
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial..
31:1007-1014.
2008
-
Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study..
31:741-746.
2008
-
Retinal arteriolar caliber predicts incident retinopathy: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study..
31:761-763.
2008
-
Evidence of a relationship between infant birth weight and later diabetes and impaired glucose regulation in a Chinese population..
31:483-487.
2008
-
Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA)..
31:544-549.
2008
-
Accuracy of perceptions of overweight and relation to self-care behaviors among adolescents with type 2 diabetes and their parents..
31:227-229.
2008
-
Caffeine increases ambulatory glucose and postprandial responses in coffee drinkers with type 2 diabetes..
31:221-222.
2008
-
Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction..
31:151-153.
2008
-
Costs of the metabolic syndrome in elderly individuals: findings from the Cardiovascular Health Study..
30:2553-2558.
2007
-
Depressive symptoms, race, and glucose concentrations: the role of cortisol as mediator..
30:2484-2488.
2007
-
Retinal vascular changes in pre-diabetes and prehypertension: new findings and their research and clinical implications..
30:2708-2715.
2007
-
Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study..
30:1742-1746.
2007
-
Characterizing young patients with diabetes and non-ST-segment elevation acute coronary syndromes..
30:731-733.
2007
-
Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine.
2022
-
Effect of A1C and Glucose on Postoperative Mortality in Noncardiac and Cardiac Surgeries.
2018